Physician

Jeffrey L St John, M.D.

According to 2025 Medicare claims, Jeffrey John, M.D. (NPI: 1750383170) practices gastroenterology in the Pittsfield, MA market, with the plurality of this provider's patient population coming from Berkshire, MA. This provider's primary affiliated billing organization is BERKSHIRE FACULTY SERVICES INC (NPI: 1548212939; TIN: 042995053) and primary practice location at 01201-4109. John is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

John's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 977 traditional Medicare patients, billed 1,586 HCPCS/CPT codes, and received $170,049 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,436 prescription claims across 775 beneficiaries totaling $1,714,805 in drug costs, led by Skyrizi On-Body (Risankizumab-Rzaa). 2019 DME data shows 11 claims. Open Payments data shows 1 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $789,056 to $1,714,805. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	871	1,806	$163,210
2016	821	1,762	$147,763
2017	826	1,753	$151,748
2018	868	1,665	$153,686
2019	827	1,624	$159,962
2020	767	1,572	$141,187
2021	777	1,617	$169,054
2022	823	1,665	$160,201
2023	927	1,530	$157,499
2024	977	1,586	$170,049

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	442	2,188	$789,056
2016	539	2,616	$774,563
2017	449	2,478	$849,216
2018	573	2,608	$1,098,087
2019	625	2,571	$1,258,517
2020	563	2,288	$1,422,986
2021	624	2,439	$1,336,542
2022	696	2,649	$1,136,171
2023	769	2,648	$1,367,695
2024	775	2,436	$1,714,805

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	24	$1,905
2018	N/R	16	$1,697
2019	N/R	11	$1,962
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	246	248	$211
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	82	83	$183
45380	Biopsy of large bowel using a flexible endoscope	349	352	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	154	169	$69
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	239	246	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi On-Body	Risankizumab-Rzaa	34	1,904	$669,714
Stelara	Ustekinumab	11	616	$258,760
Xifaxan	Rifaximin	48	1,264	$143,715
Rinvoq	Upadacitinib	12	348	$110,010
Creon	Lipase/Protease/Amylase	11	769	$79,798

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$31	Madrigal Pharmaceuticals
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey L. St John, M.D.?

Tedicare shows public-source Medicare data for Jeffrey L. St John, M.D. (NPI 1750383170), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey L. St John, M.D. have ACO affiliation data?

Jeffrey L. St John, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jeffrey L. St John, M.D.?

Jeffrey L. St John, M.D. is linked to BERKSHIRE FACULTY SERVICES INC (billing NPI 1548212939) in the available physician profile data.

Does Jeffrey L. St John, M.D. have Open Payments data?

Jeffrey L. St John, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.